𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-αtherapy for chronic hepatitis C in special patient populations

✍ Scribed by Patrick Marcellin; Nathalie Boyer; Jean-Pierre Behamou; Serge Erlinger


Publisher
Springer US
Year
1996
Tongue
English
Weight
573 KB
Volume
41
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Autoantibodies during α-interferon thera
✍ G. Fattovich; C. Betterle; L. Brollo; B. Pedini; G. Giustina; G. Realdi; A. Albe 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive

Serial density analysis of hepatitis C v
✍ Tatsuya Kanto; Norio Hayashi; Tetsuo Takehara; Hideki Hagiwara; Eiji Mita; Masah 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

## Abstract In interferon treatment of chronic hepatitis C patients, the biochemical and virological responses mostly parallel each other. However, some patients who show persistent ALT normalization display continued viremia after cessation of therapy. High‐density hepatitis C virus (HCV) particle

10-year follow-up after interferon-α the
✍ Dr. Daryl T. Lau; David E. Kleiner; Marc G. Ghany; Yoon Park; Peter Schmid; Jay 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Sustained responses to interferon-alpha occur in 10% to 25% of patients with chronic hepatitis C, but the long-term outcome is not well defined. We evaluated the long-term clinical, histological, and virological outcomes of 10 patients with chronic hepatitis C who were treated between 1984 and 1987